A Medical Director reviews a study where patients were randomly assigned to treatment or control groups, and neither patients nor researchers knew who received the treatment. What study design is this?
-
A
Open-label randomized trial
-
B
Double-blind randomized controlled trial
-
C
Prospective cohort study
-
D
Crossover observational study